药物发现
医学
药理学
数据科学
制药工业
计算机科学
生物信息学
生物
作者
Daniel A. Erlanson,Stephen W. Fesik,Roderick E. Hubbard,Wolfgang Jahnke,Harren Jhoti
摘要
Fragment-based methods have made substantial contributions to drug discovery in the past 20 years, particularly for challenging targets. Erlanson and colleagues discuss progress in the field, key aspects such as the design of fragment libraries and the choice of screening technique, and how current challenges in fragment-based drug discovery might be overcome.
科研通智能强力驱动
Strongly Powered by AbleSci AI